Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Death, Esophageal Neoplasms, Glioblastoma, Lung Diseases, Lung Neoplasms, Melanoma, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Stomach Neoplasms, Thoracic Neoplasms, Urogenital Neoplasms, Disease Progression, Small Cell Lung Carcinoma

NCT03976999 2025-02-12

BCBOvaire

Phase NA Recruiting

300 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Peritoneal Neoplasms

NCT06785077 2025-01-20

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Phase NA Recruiting

157 enrolled

Classical hematologyGynecologicOther hematologic neoplasm

Carcinoma, Ovarian Epithelial, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT05444270 2023-11-24

SABR-ROC

Phase NA Recruiting

270 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

Clinical Trials

Melisa-II

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

PlatinOv

Genetic Testing Decision Aid

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

BCBOvaire

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

SABR-ROC